Insights

Strategic partnerships ARIZ aims to advance from pre-clinical to clinical development through collaborations with pharmaceutical companies, creating opportunities to position potential drug candidates for co-development, licensing, or strategic investments.

Targeted oncology focus The company specializes in targeting PRDM gene deregulation with proprietary siRNA constructs and novel delivery nanotechnologies, presenting a unique value proposition for partners seeking precision cancer therapeutics with reduced harm to normal cells.

Early funding signals Recent angel funding indicates investor interest and validate proof-of-principle data; potential buyers may look for collaboration or licensing discussions to accelerate clinical milestones.

Proof of principle opportunities Demonstrated selective lethality across multiple cancer types in pre-clinical models creates a strong narrative for in-licensing or joint development arrangements around multiple candidates and animal model data.

Strategic market positioning As a small biotech with a high-value addressable need in oncology, ARIZ can be a candidate for partnerships with larger gene therapy, RNA therapeutics, or precision medicine players seeking to expand PRDM-targeted pipelines.

Similar companies to ARIZ Precision Medicine

ARIZ Precision Medicine Tech Stack

ARIZ Precision Medicine uses 8 technology products and services including Linode, Weebly, WordPress, and more. Explore ARIZ Precision Medicine's tech stack below.

  • Linode
    Cloud Infrastructure Computing
  • Content Management System
  • Content Management System
  • E-commerce
  • Google Fonts API
    Font Scripts
  • JSON-LD
    Javascript Frameworks
  • Quantcast
    System Analytics & Monitoring

ARIZ Precision Medicine's Email Address Formats

ARIZ Precision Medicine uses at least 2 email formats:
ARIZ Precision Medicine Email FormatsExamplePercentage
First@arizbio.comJohn@arizbio.com
86%
FLast@arizbio.comJDoe@arizbio.com
14%

Frequently Asked Questions

What is ARIZ Precision Medicine's official website and social media links?

Minus sign iconPlus sign icon
ARIZ Precision Medicine's official website is arizbio.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does ARIZ Precision Medicine generate?

Minus sign iconPlus sign icon
As of October 2026, ARIZ Precision Medicine's annual revenue is estimated to be $1M - $10M.

What is ARIZ Precision Medicine's SIC code and NAICS code?

Minus sign iconPlus sign icon
ARIZ Precision Medicine's SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does ARIZ Precision Medicine have currently?

Minus sign iconPlus sign icon
As of October 2026, ARIZ Precision Medicine has approximately 2 employees across 1 continents, including North America. Key team members include Ceo: B. N., Chief Financial Officer: K. R. and Founder, Founding Ceo, Chairman Of The Board Of Directors: L. B. Explore ARIZ Precision Medicine's employee directory with LeadIQ.

What industry does ARIZ Precision Medicine belong to?

Minus sign iconPlus sign icon
ARIZ Precision Medicine operates in the Biotechnology Research industry.

What technology does ARIZ Precision Medicine use?

Minus sign iconPlus sign icon
ARIZ Precision Medicine's tech stack includes Linode, Weebly, WordPress, Shopify, Google Workspace, Google Fonts API, JSON-LD and Quantcast.

What is ARIZ Precision Medicine's email format?

Minus sign iconPlus sign icon
ARIZ Precision Medicine's email format typically follows the pattern of First@arizbio.com. Find more ARIZ Precision Medicine email formats with LeadIQ.

How much funding has ARIZ Precision Medicine raised to date?

Minus sign iconPlus sign icon
As of October 2026, ARIZ Precision Medicine has raised $2.7M in funding. The last funding round occurred on Mar 16, 2022 for $1M.

When was ARIZ Precision Medicine founded?

Minus sign iconPlus sign icon
ARIZ Precision Medicine was founded in 2015.
ARIZ Precision Medicine logo

ARIZ Precision Medicine

Biotechnology ResearchCalifornia, United States2-10 Employees

ARIZ Precision Medicine is a pre-clinical biotechnology company pursuing cancer therapies that target early drivers such as deregulated PRDM genes. Based in Davis, California, the organization aims to destroy cancer cells with PRDM abnormalities while limiting impact on normal cells. It operates with a small team and centers its work on translating genetic insight into targeted treatment approaches.

Early studies indicate the approach can selectively kill several cancer types, including breast, colon, lung cancers and myeloma. ARIZ is advancing drug candidates into animal models to generate data and intellectual property for potential collaborations with pharmaceutical companies. The company draws on a board of experts in PRDM biology, drug delivery and development to guide its research.

Section iconCompany Overview

SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2015
Employees
2-10

Section iconFunding & Financials

  • $2.7M

    ARIZ Precision Medicine has raised a total of $2.7M of funding over 3 rounds. Their latest funding round was raised on Mar 16, 2022 in the amount of $1M as a Convertible Note.

  • $1M - $10M

    ARIZ Precision Medicine's revenue is estimated to be in the range of $1M - $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.